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SCIENTIFIC OPINION 
Scientific Opinion on the safety and efficacy of Bacillus subtilis KCCM 
10673P and Aspergillus oryzae KCTC 10258BP as feed additives for all 
animal species
1
 
EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP)
2,3
 
European Food Safety Authority (EFSA), Parma, Italy 
This scientific opinion has been amended following the adoption of the decision of the Commission on 
confidentiality claims submitted by the applicant, in accordance with Article 8(6) and Article 18 of Regulation 
(EC) No 1831/2003. The modified section is indicated in the text. 
ABSTRACT 
PepSoyGen-C is described as pure cultures of Aspergillus oryzae and Bacillus subtilis added simultaneously to 
feed materials to reduce antinutritional factors. The applicant is seeking its authorisation as a technological 
additive, under a newly proposed, currently non-existent functional group, “substances for the reduction of anti-
nutritional factors”. The Panel on Additives and Products or Substances used in Animal Feed (FEEDAP) 
considers that the two microbial cultures should be regarded as two independent feed additives that are the 
subject of the evaluation. The additives are poorly characterised. The inclusion level is likely to be 2 % by 
weight of the total substrate. The ratio of the two cultures is described as 50/50 on a weight basis. A dose 
expressed in colony-forming units per kilogram of feed is not proposed. No evidence of toxigenic potential or 
resistance to antibiotics of human and veterinary importance was found, according to the current guidance 
documents. Therefore, the B. subtilis additive is presumed safe for target animals, consumers of products fed the 
additive and the environment. The B. subtilis additive should be considered as having the potential to be a skin 
and eye irritant and a skin sensitiser and be treated accordingly. In the absence of data on production of toxic 
secondary metabolites in A. oryzae, the FEEDAP Panel cannot draw conclusions on its safety for the target 
species and consumers of products fed the additive. The A. oryzae additive should be considered as having the 
potential to be a skin and eye irritant and a skin and respiratory sensitiser and be treated accordingly. The use of 
the additive as a technological feed additive is not expected to pose a risk to the environment. The FEEDAP 
Panel cannot draw conclusions on the efficacy of the additives in reducing antinutritional factors in soybean and 
other feed materials. 
© European Food Safety Authority, 2015 
KEY WORDS 
technological additive, substances for the reduction of antinutritional factors, Bacillus subtilis KCCM 10673P, 
Aspergillus oryzae KCTC 10258BP, safety, efficacy, soybean 
                                                     
1 On request from the European Commission, Question No EFSA-Q-2009-00525, adopted by the FEEDAP Panel on 
8 September 2015. 
2 Panel members: Gabriele Aquilina, Vasileios Bampidis, Maria de Lourdes Bastos, Georges Bories, Andrew Chesson, Pier 
Sandro Cocconcelli, Maria Luisa Fernandez-Cruz, Gerhard Flachowsky, Jürgen Gropp, Boris Kolar, Maryline Kouba, 
Secundino Lopez Puente, Marta Lopez-Alonso, Alberto Mantovani, Baltasar Mayo, Fernando Ramos, Guido Rychen, 
Maria Saarela, Roberto Edoardo Villa, Robert John Wallace and Pieter Wester. Correspondence: feedap@efsa.europa.eu  
3 Acknowledgement: The European Food Safety Authority wishes to thank the members of the Working Group on 
Microorganisms, including Ingrid Halle, for the preparation of this opinion.  
 
B. subtilis KCCM 10673P and A. oryzae KCTC 10258BP for all animal species 
 
 
2 EFSA Journal 2015;13(9):4230 
SUMMARY 
Following a request from the European Commission, the Panel on Additives and Products or 
Substances used in Animal Feed (FEEDAP) was asked to deliver a scientific opinion on the safety and 
efficacy of the product PepSoyGen-C as a feed additive for all animal species. The additive is said to 
be composed of a mixture of pure cultures of Aspergillus oryzae and of Bacillus subtilis. 
PepSoyGen-C is intended to treat feed materials such as soybean meal for use in all animal species in 
order to reduce antinutritional factors. For this purpose the applicant is seeking an authorisation for 
PepSoyGen-C as a technological additive under a newly proposed, currently non-existent functional 
group, “substances for the reduction of antinutritional factors”. The FEEDAP Panel considers that the 
two microbial cultures should be regarded as two independent feed additives that are the subject of the 
evaluation. 
The additives are poorly characterised. They are said to be combined only at the point of application to 
the target feed. The applicant indicates that the inclusion level is likely to be 2 % by weight of the total 
substrate (20 g/kg feed material). The ratio of the two cultures is described as 50/50 on a weight basis. 
A dose expressed as colony-forming units per kilogram of feed is not proposed. 
No evidence of toxigenic potential or resistance to antibiotics of human and veterinary importance was 
found, judging by the current guidance documents. Therefore, B. subtilis KCCM 10673P is presumed 
safe for target animals, consumers of products fed the additive and the environment. The additive 
should be considered as having the potential to be a skin and eye irritant and a skin sensitiser and be 
treated accordingly. 
In the absence of data on production of toxic secondary metabolites, other than aflatoxins, in A. oryzae 
KCTC 10258BP, the FEEDAP Panel cannot draw conclusions on its safety for the target species and 
the consumer of products fed the additive. The additive should be considered as having the potential to 
be a skin and eye irritant and a skin and respiratory sensitiser and be treated accordingly. The use of 
the additive as a technological feed additive is not expected to pose a risk to the environment. 
A single in vitro study was provided in which the concentrations of stachyose, raffinose and trypsin 
inhibitor were measured in multiple batches of soybean meal after treatment with the additives. 
However, as the study suffers from a number of deficiencies, the FEEDAP Panel is not in a position to 
draw conclusions on the efficacy of the additives in reducing antinutritional factors in soybean and 
other feed materials. 
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BACKGROUND 
Regulation (EC) No 1831/2003
4
 establishes the rules governing the Community authorisation of 
additives for use in animal nutrition. In particular, Article 4(1) of that Regulation lays down that any 
person seeking authorisation for a feed additive or for a new use of a feed additive shall submit an 
application in accordance with Article 7. 
The European Commission received a request from the company Regal BV
5
 for authorisation of 
PepSoyGen-C, Bacillus subtilis KCCM 10673P and Aspergillus oryzae KCTC 10258BP, to be used as a 
feed additive for piglets, chickens for fattening, calves for fattening and for rearing, fish (salmonidae 
and other fish), lambs and goats for rearing and fattening, and dogs (category: zootechnical additive; 
functional group: other zootechnical additives) under the conditions mentioned in Table 1. During the 
assessment, the applicant requested a change in the category from “zootechnical additive” to 
“technological additive”, in the functional group from “other zootechnical additives” to a new functional 
group of “substances for the reduction of anti-nutritional factors” and in the target animals from the 
above list to “all animal species”. Table 1 was modified accordingly. 
According to Article 7(1) of Regulation (EC) No 1831/2003, the Commission forwarded the application 
to the European Food Safety Authority (EFSA) as an application under Article 4(1) (authorisation of a 
feed additive or new use of a feed additive). EFSA received directly from the applicant the technical 
dossier in support of this application.
6
 According to Article 8 of that Regulation, EFSA, after verifying 
the particulars and documents submitted by the applicant, shall undertake an assessment in order to 
determine whether the feed additive complies with the conditions laid down in Article 5. The particulars 
and documents in support of the application were considered valid by EFSA as of 29 January 2010. 
The additive PepSoyGen-C is a preparation of Bacillus subtilis KCCM 10673P and Aspergillus oryzae 
KCTC 10258BP. This product has not been previously authorised in the European Union. 
TERMS OF REFERENCE 
According to Article 8 of Regulation (EC) No 1831/2003, EFSA shall determine whether the feed 
additive complies with the conditions laid down in Article 5. EFSA shall deliver an opinion on the 
safety for the target animals, consumer, user and the environment and the efficacy of Bacillus subtilis 
KCCM 10673P and Aspergillus oryzae KCTC 10258BP, when used under the conditions described in 
Table 1. 
                                                     
4 Regulation (EC) No 1831/2003 of the European Parliament and of the Council of 22 September 2003 on additives for use in 
animal nutrition. OJ L 268, 18.10.2003, p. 29.  
5 Regal BV on behalf of Nutraferma Co, Wilhelminalaan 90, 6042 EP Roermond, the Netherlands. 
6 EFSA Dossier reference: FAD-2009-0007. 
B. subtilis KCCM 10673P and A. oryzae KCTC 10258BP for all animal species 
 
 
5 EFSA Journal 2015;13(9):4230 
Table 1: Description and conditions of use of the additive as proposed by the applicant  
Additive  Bacillus subtilis GR-101 and Aspergillus oryzae GB-107  
Registration number/ 
EC No/No  
 
Category of additive 1. Technological additives 
Functional group of additive 
Substances for the reduction of anti-nutritional factors: substances or, 
where applicable microorganisms which reduce or remove anti-nutritional 
factors from feed (in accordance with SANCO reference: 3933683) 
 
Description 
Composition, description 
Chemical 
formula 
Purity criteria 
 
Method of analysis 
 
Bacillus subtilis GR-101 and 
Aspergillus oryzae GB-107 
- - 
NEN-EN15784 (2009) 
US/FDA CFSAN-BAM 
2001 
 
Trade name  - 
Name of the holder of 
authorisation  
- 
 
Conditions of use 
Species or 
category of animal 
Maximum 
Age 
Minimum content Maximum content Withdrawal 
period 
 CFU/kg of complete feedingstuffs 
All species - - - - 
 
Other provisions and additional requirements for the labelling 
Specific conditions or restrictions for 
use  
To be used to treat feed materials to diminish anti-nutritional factors. 
The additive as such will not be brought on the market, only treated 
feed materials 
Specific conditions or restrictions for 
handling 
-  
Post-market monitoring 
 
- 
Specific conditions for use in 
complementary feedingstuffs  
- 
 
Maximum Residue Limit (MRL)  
Marker residue 
Species or category of 
animal 
Target tissue(s) or 
food products 
Maximum content in 
tissues 
- - - - 
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ASSESSMENT 
1. Introduction 
This opinion is based on data provided by the applicant on a soybean meal (intended to be sold under 
the trade name PepSoyGen) fermented by the additive PepsSoyGen-C, composed of pure cultures of 
Aspergillus oryzae and Bacillus subtilis. The additive is intended to be used as a technological feed 
additive, under a newly proposed, currently non-existent, functional group, “substances for the reduction 
of anti-nutritional factors” in feedingstuffs for all animal species. 
The Panel on Additives and Products or Substances used in Animal Feed (FEEDAP) for the purpose of 
this assessment considers that the feed material soybean should not be regarded as a feed additive and 
that the two microbial cultures should be regarded as two independent feed additives intended to be 
added to feed materials to reduce antinutritional factors. These two microbial cultures are the subject of 
the evaluation. 
The bacterial species B. subtilis is considered by EFSA to be suitable for the qualified presumption of 
safety (QPS) approach to safety assessment (EFSA, 2007; EFSA BIOHAZ Panel, 2013). This approach 
requires the identity of the strain to be conclusively established and requires evidence that the strain 
lacks toxigenic potential and does not show resistance to antibiotics of human and veterinary 
importance. 
2. Characterisation 
2.1. Characterisation of the active agents 
2.1.1. Characterisation of Bacillus subtilis 
The active agent is made of viable cells of B. subtilis of unknown origin. The strain is deposited in the 
Korean Culture Center of Microorganisms with the accession number KCCM 10673P.
7
 It has not been 
genetically modified. Its identity was obtained by biochemical tests and by sequence analysis of the 
complete 16S rRNA gene.
8
 Information on its genetic stability was not provided. 
Antimicrobial susceptibility was tested by the disc agar technique and by broth dilution.
9
 The tests 
included the battery of antibiotics listed in the Technical Guidance on the update of the criteria used in 
the assessment of bacterial resistance to antibiotics of human and veterinary importance (EFSA 
FEEDAP Panel, 2012). No minimum inhibitory concentration (MIC) value of the antimicrobials tested 
against the B. subtilis strain was identified above the cut-off values; therefore, B. subtilis KCCM 
10673P is susceptible to the antibiotics tested. 
The assessment of the toxigenic potential of B. subtilis KCCM 10673P was made in accordance with the 
Technical Guidance on the assessment of the toxigenic potential of Bacillus species used in animal 
nutrition (EFSA FEEDAP Panel, 2011). Polymerase chain reaction (PCR) testing for non-ribosomally 
synthesised peptides was carried out, and the primers for surfactin biosynthesis genes were those 
described by Tapi et al. (2010).
10
 The results showed the strain to be positive for surfactin biosynthesis 
genes. Cytoxicity of the strain was assessed on Vero cells using the culture supernatants (Lindbäck and 
Granum, 2005).
11
 No evidence of cytotoxicity was seen with the non-concentrated culture supernatants, 
as required by the revised Guidance (EFSA FEEDAP Panel, 2014). Consequently, this strain is 
considered to be non-toxigenic. 
                                                     
7 Technical dossier/Supplementary information February 2015/Section II/Annexes 2.2.1.2.c. 
8 Technical dossier/ Supplementary information February 2015/Section II/Annexes 2.2.1.2.a,b. 
9 Technical dossier/Supplementary information February 2015/Section II/Annexes 2.2.2.2.a,b. 
10 Technical dossier/ Supplementary information February 2015/Section II/Annex 2.2.2.2.c. 
11 Technical dossier/ Supplementary information February 2015/Section II/Annex 2.2.2.2.m.  
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2.1.2. Characterisation of Aspergillus oryzae 
The active agent is made of viable cells of A. oryzae of unknown origin. It is deposited in the Korean 
Culture Center of Microorganisms with the accession number KCTC 10258BP.
12
 It has not been 
genetically modified. It was identified by sequence analysis of the DNA internal transcribed spacer and 
5.8S rRNA gene.
13
 Information on the genetic stability of the strain was not provided. 
The absence of the metabolic pathways for aflatoxin production in A. oryzae KCTC 10258BP was 
investigated via PCR by searching for the following genes: 
 apa-2, coding for the regulatory protein AflR, a transcriptional activator of aflatoxin 
biosynthesis (Chang et al., 1993); 
 ver-1 encoding versicolorin A dehydrogenase, which converts versicolorin A to 
sterigmatocystin (Chang et al., 1992; Skory et al., 1992); 
 omt-1 gene encodes sterigmatocystin-O-methyltransferase and is required for conversion of 
demethylsterigmatocystin and dehydrodemethylsterigmatocystin to sterigmatocystin and 
dihydrosterigmatocystin, respectively. 
None of the genes of the biosynthetic pathways for aflatoxin production was detected in A. oryzae 
KCTC 10258BP, and this is considered an adequate approach to exclude aflatoxin synthesis (Kim et al., 
2014).
14
 
No information was provided on the potential for production of other secondary metabolites of concern, 
including antibiotics such as penicillin, whose biosynthetic pathways are known to occur in strains of 
A. oryzae (Inglis et al., 2013). 
2.2. Characterisation of the additives15 
The manufacturing process of B. subtilis is fully described in the dossier. The product is in liquid form. 
No minimum content of colony-forming units (CFU) per gram of additive was declared, and the only 
information available is based on an analysis of five batches of the pure culture, which shows a mean of 
4.3 × 10
8
 CFU/g (range: 3.7–5.3 × 108 CFU/g).16 
The manufacturing process of A. oryzae is fully described in the dossier. The product is in solid form. is 
grown on a semi-solid medium containing wheat bran and the resulting biomass is spray dried. 
Similarly, no minimum content of colony-forming units per gram of additive was specified, and the only 
information available is based on an analysis of five batches of the pure culture, which shows a mean of 
2.7 × 10
8
 CFU/g (range: 2.2–3.0 × 108 CFU/g).17 
No information on chemical and microbiological impurities was provided for the additives. 
The particle size distribution and dusting potential of the A. oryzae additive were not provided. 
Shelf-life data were provided in relation to the proposed use of the product (see section 2.3). Three 
batches of B. subtilis held under refrigeration were shown to be stable for five days.
18
 No data for the 
A. oryzae culture were provided. 
                                                     
12 Technical dossier/Supplementary information February 2015/Section II/Annexes 2.2.1.2.d. 
13 Technical dossier/Supplementary information February 2015/Section II/Annex 2.2.1.2.e. 
14 Technical dossier/Supplementary information February 2015/Section II/Annex 2.2.2.2.p. 
15 This section has been amended following the provisions of Article 8(6) and Article 18 of Regulation (EC) No 1831/2003. 
16 Technical dossier/Supplementary information February 2015/Annex 2.1.3.a. 
17 Technical dossier/Supplementary information February 2015/Annex 2.1.3.a. 
18 Technical dossier/Supplementary information February 2015/Section II. 
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The additives are foreseen for addition to feedingstuffs (e.g. soybean) as “substance for reduction of 
antinutritional factors”. No further demonstration of the stability of the additives in feedingstuffs and of 
their homogeneous distribution is considered necessary, once the efficacy has been demonstrated. 
2.3. Conditions of use 
The applicant stated that the additives will not be marketed to feed manufacturers or farmers but used by 
the applicant to treat feed materials (e.g. soybean meal) for all animal species.
19
 
The two additives are said to be combined only at the point of application to the target feed. The 
applicant indicates that the inclusion level is likely to be 2 % by weight of the total substrate (20 g/kg 
feed material). The ratio of the two cultures is described as 50/50 on a weight basis. A dose expressed in 
CFU/kg feed is not proposed. 
2.4. Evaluation of the analytical methods by the European Union Reference Laboratory 
(EURL) 
EFSA has verified the EURL report as it relates to the methods used for the control of the active agents 
in animal feed. The executive summary of the EURL report can be found in Annex A. 
3. Safety 
3.1. Bacillus subtilis KCCM 10673P 
The species B. subtilis is considered by EFSA to be suitable for the QPS approach to safety assessment 
(EFSA, 2007; EFSA BIOHAZ Panel, 2013). In the view of the FEEDAP Panel, the identity of the 
production strain is established as B. subtilis. Moreover, the toxigenic potential and the antibiotic 
resistance qualifications have been met. Therefore, B. subtilis KCCM 10673P is presumed safe for the 
target species, the consumer and the environment. 
No data are provided on the potential of the additive to induce skin/eye irritation or skin sensitisation. 
Therefore, the additive should be considered as having the potential to be a skin and eye irritant and a 
skin sensitiser and be treated accordingly. 
3.2. Aspergillus oryzae KCTC 10258BP 
A. oryzae is not considered by EFSA to be suitable for a QPS approach to safety assessment. 
3.2.1. Safety for the target animals 
No tolerance studies were submitted by the applicant. In the absence of these and of data on the 
potential for production of toxic secondary metabolites (other than aflatoxins) and antimicrobial activity 
in the A. oryzae additive, the FEEDAP Panel cannot draw conclusions on its safety for target animals 
given feed materials produced using the additive. 
3.2.2. Safety for the consumer 
The additive is intended to grow in the target feed. In the absence of information on the potential for 
production of toxic secondary metabolites (other than aflatoxins), the FEEDAP Panel is not in the 
position to assess whether hazardous residues derived from the use of A. oryzae KCTC 10258BP are 
present in animal tissues or products. 
3.2.3. Safety for the user 
No information was available on the particle size and dusting potential of the additive. No data were 
provided on the potential of the additive to induce skin/eye irritation or skin sensitisation. Therefore, the 
additive should be considered as having the potential to be a skin and eye irritant and a skin sensitiser 
                                                     
19 Technical dossier/Supplementary information February 2015/Section II. 
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and be treated accordingly. The potential for users to be exposed to dust from the additive could not be 
excluded. In addition, given the proteinaceous nature of the active agent, the additive should also be 
considered to have the potential to be a respiratory sensitiser and treated accordingly. 
3.2.4. Safety for the environment 
A. oryzae is ubiquitous in nature. Its use as a technological feed additive is not expected to pose a risk to 
the environment. 
4. Efficacy 
The function of the additives is described as a treatment for feed materials (e.g. soybean) to reduce 
antinutritional factors such as raffinose, stachyose and trypsin inhibitor factor. 
An outline description of a single in vitro study was provided in which the concentrations of stachyose, 
raffinose and trypsin inhibitor were measured in multiple batches of soybean meal after treatment with 
the additives.
20
 However, the values of these antinutritional factors before treatment were not 
determined. Instead reference was made to published values of different soybeans used in animal 
nutrition (conventional and low-trypsin-inhibitor raw or heated soybean and soybean meal).
21
 The study 
suffers from the following deficiencies: (i) the dose of the additives added to the feed material is not 
reported: (ii) the feed material used is not characterised (e.g. raw or heated soybean, whole grain or 
meal); (iii) the initial concentration of antinutritional factors was not measured; (iv) no demonstration of 
efficacy for feed materials other than soybean was provided. 
Considering the above, the FEEDAP Panel is not in a position to draw conclusions on the efficacy of the 
additives in reducing antinutritional factors in soybean and other feed materials. 
CONCLUSIONS 
The additives A. oryzae KCTC 10258BP and B. subtilis KCCM 10673P were insufficiently 
characterised. 
The liquid preparation B. subtilis KCCM 10673P is presumed safe for the target species, consumers and 
the environment. It should be considered to be a skin and eye irritant and a skin sensitiser. 
Concerning the solid preparation of A. oryzae KCTC 10258BP, in the absence of data on toxic 
secondary metabolites (other than aflatoxins) and on the potential for antibiotic production, the 
FEEDAP Panel cannot draw conclusions on its safety for the target species and the consumer. The 
additive should be considered to be a skin and eye irritant and a skin and respiratory sensitiser. Its use is 
not expected to pose a risk to the environment. 
The FEEDAP Panel cannot draw conclusions on the efficacy of the additives in reducing antinutritional 
factors in soybean and other feed materials. 
REMARK 
In the view of the FEEDAP Panel, the functional group “substances for the reduction of antinutritional 
factors” needs a definition. The endpoints for assessing the efficacy and the safe use of any additive 
assigned to this functional group should be defined. 
  
                                                     
20 Technical dossier/Supplementary information February 2015/Section IV/Annexes 4.1a–d. 
21 Technical dossier/Supplementary information September 2013/Section IV/Annex 4.1d. 
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ANNEX 
Executive Summary of the Evaluation Report of the European Union Reference Laboratory for 
Feed Additives on the Methods of Analysis for PepSoyGen-C
1
 
In the current application authorisation is sought for the probiotic PepSoyGen-C, which consists of 
two active agents Bacillus subtilis GR-101 and Aspergillus oryzae GB-107,
2
 under the category 
‘zootechnical additives’, functional group ‘other zootechnical additives’ according to Annex I of 
Regulation (EC) No 1831/2003. Specifically, authorization is sought for the use of Bacillus subtilis 
GR-101 and Aspergillus oryzae GB-107 for piglets, chicken for fattening, calves for fattening and for 
rearing, fish (salmonidae and other fish), lambs and goats for rearing and fattening and for dogs.
3
 The 
product is to be used to treat feed materials to diminish anti-nutritional factors and will enter animals 
in live form. The proposed conditions of use do not include minimum or maximum concentrations of 
the feed additive. According to the applicant the product as such will not be placed on the market, but 
feed materials previously treated with the product. 
For the enumeration of Bacillus subtilis GR-101 in premixtures and feedingstuffs the CEN method (EN 
15784) has been validated at a range between 10
5
 and 10
9
 CFU/g. The performance characteristics of 
the CEN method reported after logarithmic transformation of measured values (CFU) are: 
 for the premixtures: (1) a standard deviation for repeatability (sr) of 0.09 log10 CFU/g and (2) a 
standard deviation for reproducibility (sR) of 0.32 log10
 
CFU/g. 
 for the feedingstuffs: (1) sr = 0.07 log10 CFU/g and (2) sR = 0.35 log10 CFU/g and 
 a limit of detection (LOD) of 1 × 105 CFU/kg in feedingstuffs. 
However, since this specific application does not include target levels of Bacillus subtilis GR-101 in 
feedingstuffs, the EURL cannot evaluate the suitability of this CEN standard. 
For the enumeration of Aspergillus oryzae GB-107 the applicant proposes internationally recognised 
US FDA/CFSAN BAM spread plate method for enumeration of yeasts, moulds and mycotoxins. The 
applicant considers that further validation or verification is not necessary since this is an official US 
method. However another international standard exists for the enumeration of yeasts and moulds (ISO 
21527–1). No performance characteristics of this spread plate method were provided except the LOD 
of 1 x 10
5
 CFU/kg in feed. As this method was not tested on the product, the EURL cannot evaluate 
the suitability of this ISO method for official control. Molecular methods were used by the applicant 
for identification of active agents. The EURL recommends for official control for Bacillus subtilis GR-
101, Pulsed Field Gel Electrophoresis (PFGE), a generally recognised standard methodology for 
bacterial identification. For Aspergillus oryzae GB-107 the EURL recommends for official control 
Polymerase Chain Reaction (PCR), generally recognised standard methodology for identification of 
yeasts and moulds. 
Further testing or validation is not considered necessary. 
                                                     
1 The full report is available on the EURL website: https://ec.europa.eu/jrc/sites/default/files/FinRep-FAD-2009-0007.pdf 
2 GR-101 and GB-107 are in-house identifiers for Bacillus subtilis KCCM 10673P and Aspergillus oryzae KCTC 10258BP, 
respectively. 
3 In the course of the assessment, the applicant requested a change in the category from “zootechnical additive” to 
“technological additive”, in the functional group from “other zootechnicals” to “substances for the reduction of anti-
nutritional factors” and in the target animals from the above list to “all animal species”. 
